| abstract |
REFERS TO THE USE OF ANTIFUNGALS AND HERBICIDES TOGETHER WITH REINFORCEMENTS AND / OR ANTIVIRAL AGENTS AND / OR CHEMOTHERAPEUTIC AGENTS, IN THE TREATMENT OF VIRAL INFECTIONS, LIKE HIV, AND CANCER; WHERE: THE ANTIFUNGAL IS A DERIVATIVE OF BENZMIDAZOLE, TIABENCIMIDAZOLE, 1H-1,2,4-TRIAZOL, 1,3-BIS-TRIAZOLIL-2-PROPANOL, GRISEOFULVINE, OF PREFERENCE SAID FUNGICIDE IS TIABENDAZOLE; THE HERBICIDE IS A DERIVATIVE OF N-CHLOROPHENYL CARBAMATE AND N-CHLOROPHENYLTIOCARBAMATE, N-PHOSPHONOGLYCIN, PREFERRED SAID HERBICIDE IS CHLOROPROFAN; THE REINFORCER IS THE ACID 1-H-BENCIMIDAZOLE-2-PROPANOIC (PROCODAZOLE), AMONG OTHERS; THE ANTIVIRAL AGENT IS AZT or 3TC; CHEMOTHERAPEUTIC AGENT IS AN INTERACTIVE DNA AGENT, INTERACTIVE AGENT OF TUBULIN or ANTIMETABOLITE LIKE: ASPARAGINASE, HYDROXYUREA, CISPLATIN, CYTLOPHAMIDE, BLEOMYCIN, DIPINOMYCIN, DIPINOMYCIN, DOXORINE HERBICIDAL AGENTS ARE EFFECTIVE WHEN CANCER OR VIRUSES ARE A GENETICALLY ALTERED ANIMAL CELL AND FUNGICIDAL AGENTS ARE EFFECTIVE WHEN CANCER OR VIRUSES ARE AN ANIMAL CELL CONTAINING GENETIC MATERIALS DERIVED FROM FUNGI OR MOHOS |